Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/1998
08/06/1998WO1998033802A1 Quinazolinone compounds
08/06/1998WO1998033798A2 Pyrido[2,3-d]pyrimidines and 4-amino-pyrimidines as inhibitors of cell proliferation
08/06/1998WO1998033788A1 Matrix metalloproteinase inhibitors
08/06/1998WO1998033768A1 Arylsulfonylamino hydroxamic acid derivatives
08/06/1998WO1998033527A2 Cancer immunotherapy with semi-allogeneic cells
08/06/1998WO1998033519A1 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same
08/06/1998WO1998033509A2 Useful properties of human lactoferrin and variants thereof
08/06/1998WO1998033506A1 Androgen synthesis inhibitors
08/06/1998WO1998033486A1 Microparticles and their use in cancer treatment
08/06/1998WO1998033485A1 Method for removing high boiling solvents from drug formulations by vacuum drying
08/06/1998WO1998033481A1 Lipid complexes and liposomes of highly insoluble platinum complexes
08/06/1998WO1998033470A2 Substituted perylenequinones for use in photodynamic therapy
08/06/1998WO1998024906A3 Isolated mammalian monocyte cell genes; related reagents
08/06/1998WO1998022587A3 Pituitary-tumor-transforming-genes, and related products
08/06/1998WO1998021332A3 Secreted proteins and polynucleotides encoding them
08/06/1998WO1998010794A3 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
08/06/1998CA2279991A1 Human anion channel
08/06/1998CA2279548A1 Ribozymes cleaving epidermal growth factor receptors
08/06/1998CA2279265A1 Novel human cystatin-like protein
08/06/1998CA2278849A1 A tumor suppressor designated ts10q23.3
08/06/1998CA2278848A1 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use
08/06/1998CA2278847A1 Method for the production of selected lymphocytes
08/06/1998CA2278678A1 Cancer immunotherapy with semi-allogeneic cells
08/06/1998CA2278595A1 Secreted proteins and polynucleotides encoding them
08/06/1998CA2277362A1 Substituted perylenequinones for use in photodynamic therapy
08/06/1998CA2271157A1 Pyrido[2,3-d]pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation
08/06/1998CA2222981A1 Promoter of the human endoglin gene and its use
08/05/1998EP0856579A1 An antisense oligonucleotide preparation method
08/05/1998EP0856512A2 1-deoxy paclitaxels, method of preparation and pharmaceutical use
08/05/1998EP0856259A1 Composition for feed use comprising lyophilized live lactic bacteria
08/05/1998EP0856157A1 Tumour-specific p450 protein
08/05/1998EP0856062A2 Herpesvirus vectors and their uses
08/05/1998EP0856051A1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof
08/05/1998EP0856050A1 Transforming growth factor alpha hi
08/05/1998EP0856007A1 Cyclopeptide derivatives
08/05/1998EP0855911A1 Namenamicin, an enediyne antitumor antibiotic from the marine ascidian polysyncraton lithostrotum
08/05/1998EP0855909A1 Radiosensitizing taxanes and their pharmaceutical preparations
08/05/1998EP0831819A4 Method for inhibiting neoplastic disease in mammals
08/05/1998EP0698019B1 Novel aromatic nitro compounds and their metabolites useful as anti-viral and anti-tumor agents
08/05/1998EP0690872B1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
08/05/1998EP0641342B1 Antiviral 2-ethyl-1h-imidazo(4,5-c)quinolin-4-amines
08/05/1998CN1189775A Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
08/05/1998CN1189500A Process of preparing etoposide phosphate and etoposide
08/05/1998CN1189499A Process of preparing etoposide phosphate and etoposide
08/05/1998CN1189497A Process of preparing etoposide phosphate and etoposide
08/05/1998CN1189491A Isoxazole and crotonamide derivatives and their use as pharmaceuticals and disgnositics
08/05/1998CN1189352A Chinese herbal medicine for treating hysteromyoma and breast fibrosarcoma and its prepn. method
08/05/1998CN1039414C Bis-naphthalimides compounds
08/05/1998CA2221687A1 Tumor necrosis related receptor, tr5
08/04/1998US5789605 Discodermolides; anticarcinogenic agents; immunosuppressants; sponges; reacting a 1,3-dioxanyl-containing phosphonium salt with a base and furan-containing alkyl thiol
08/04/1998US5789562 Nucleotide monomers containing 8-azapurin bases or a derivative thereof, their preparation and their use in making modified olignonucleotides
08/04/1998US5789554 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells
08/04/1998US5789551 Human leukocyte interferon Hu-IFN-α001
08/04/1998US5789550 TRAF inhibitors
08/04/1998US5789447 Nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
08/04/1998US5789434 Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
08/04/1998US5789432 Aromatase-inhibiting composition containing azole derivative
08/04/1998US5789418 Bis-naphthalimides for the treatment of cancer
08/04/1998US5789417 Anticarcinogenic agents
08/04/1998US5789414 Protect dna from damage
08/04/1998US5789405 Oxaspiro(2,5)octane derivative
08/04/1998US5789248 CAPL-specific oligonucleotides and method of inhibiting metastatic cancer
08/04/1998US5789200 Polypeptides and dna(rna) codes by genetic engineering for diagnosis and treatment of cancer, prostate, breast, lung or epithelial tumors
08/04/1998US5789187 Identification of differentiation factor receptors which inhibit the tumorigenicity of neuroblastoma cells in a ligand-independent manner
08/04/1998US5789021 Coated layer of phosphor particles in a binder
08/04/1998US5789000 Mixture with 2,2'-dithio-bis-ethane sulfonate
08/04/1998US5788985 Comprising n-glycidyl ganglioside coupled to carier protein, adjuvant
08/04/1998US5788984 Gestodene-containing agent for transdermal administration
08/04/1998US5788964 Method for sensitization of cancer cells for killer cell mediated lysis
08/04/1998US5788963 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
08/04/1998US5788958 Using nitrous oxide synthase inhibitor
08/04/1998US5788953 Comprising water having lowered deuterium content
08/04/1998CA2047090C Genetic mechanisms of tumor suppression
08/04/1998CA1339980C Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same
08/03/1998CA2220852A1 Tumor necrosis related receptor, tr4
07/1998
07/30/1998WO1998032865A1 Novel prostate-associated kallikrein
07/30/1998WO1998032854A1 Human apoptosis-associated protein; encoding dna is similar to p53 response mouse gene ei124
07/30/1998WO1998032766A1 SUBSTITUTED AMINO BICYCLIC-β-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
07/30/1998WO1998032749A1 Tetrahydrofuran derivatives
07/30/1998WO1998032718A1 New fatty acid derivatives
07/30/1998WO1998032463A2 Lyophilizate of lipid complex of water insoluble porphyrins
07/30/1998WO1998032444A1 USE OF FXR, PPARα AND LXRα ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION
07/30/1998WO1998032440A1 Kit for inhibiting the growth of cancers, comprising a chemotherapeutic agent and a benzimidazole, and optionally a potentiator
07/30/1998WO1998027108A3 New amide compounds and their use as nitric oxide synthase inhibitors
07/30/1998WO1998025598A3 Methods and pharmaceutical compositions for inhibiting tumour cell growth
07/30/1998WO1998024780A3 Substituted pyrimidinone and pyridinone compounds and their use
07/30/1998WO1998024478A3 Tumour therapy
07/30/1998WO1998021237A3 Peptide compounds useful for modulating FGF receptor activity
07/30/1998DE19718245C1 Synthetic tri:glyceride(s) useful as food additives
07/30/1998CA2279260A1 Human apoptosis-associated protein; encoding dna is similar to p53 response mouse gene ei124
07/30/1998CA2278779A1 Substituted amino bicyclic-.beta.-lactam penam and cepham derivatives as cysteine protease inhibitors
07/30/1998CA2278623A1 Novel prostate-associated kallikrein
07/30/1998CA2278123A1 Use of fxr, ppar.alpha. and lxr.alpha. activators to restore barrier function, promote epidermal differentiation and inhibit proliferation
07/30/1998CA2277333A1 Tetrahydrofuran derivatives
07/30/1998CA2277166A1 Kit for inhibiting the growth of cancers, comprising a chemotherapeutic agent and a benzimidazole, and optionally a potentiator
07/29/1998EP0855444A2 Aspartic proteinase 2 (ASP2)
07/29/1998EP0855443A2 cDNA clone HE8CH90 that encodes a 7-transmembrane receptor
07/29/1998EP0855442A2 Central nervous system transcription regulator polypeptide and a DNA sequence to which a protein containing the polypeptide binds
07/29/1998EP0855402A1 Novel terpenoid compound 0406TP-1
07/29/1998EP0855185A2 Host-vector system for use in gene therapy
1 ... 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 ... 2211